Daily Cardiology Academy

Daily cardiology

to enjoy learning and progressing in cardiometabolic practice

Vizitează neapărat site-ul podcastului și susține-i creatorul: shenoto.com

Autor

Daily Cardiology Academy

Categorie

Health

Site-ul podcastului

shenoto.com

Cel mai nou episod

17 nov. 2026

Unde asculți?

Podcasturi în aplicație Replaio Radio În curând

Podcasturile ajung în curând în aplicație. Instaleaz-o acum și fii primul care descoperă o abordare complet nouă a podcasturilor

Descarcă din Google Play Instalează gratuit Android 10 mil.+ descărcări · nota 4,7+ iOS în curând

Episoade

ESC 2025: Ticagrelor and Aspirin or Aspirin Alone after Coronary Surgery for Acute Coronary Syndrome 30.12.2025

📚 ESC 2025 Coverage: More Isn’t Always Better: Dual Antiplatelet Therapy Falls Short After CABG for ACS, by Dr. Mehrpouya, Interventional Cardiologist.

ESC 2025: Vericiguat for patients with heart failure and reduced ejection fraction across the risk s 29.12.2025

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum VICTORIA and VICTOR Clinical Trials 📚 ESC 2025 Coverage: Bridging Stability and Severity: Vericiguat’s Role Expands in Heart Failure Therapy, by Dr. Taghavi, Fellowship of Heart Failure.

ESC 2025: Reduction of Antihypertensive Treatment in Nursing Home Residents 28.12.2025

Reduction of Antihypertensive Treatment in Nursing Home Residents 📚 ESC 2025 Coverage: Taking the Pressure Off, Gently: Can Fewer BP Pills Help Frail Elders Thrive? by Dr. Mansouri, Internal Medicine Specialist.

ESC 2025: High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults 27.12.2025

High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults 📚 ESC 2025 Coverage: Double the Dose, Double the Defense? by Dr. Soleimani, Cardiovascular Specialist.

ESC 2025: B. Aminian, MD 27.12.2025

Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction (TARGET-FIRST)

Apixaban for Extended Treatment of Provoked Venous Thromboembolism (HI-PRO) 27.12.2025

Apixaban for Extended Treatment of Provoked Venous Thromboembolism (HI-PRO)

Impact 52: FINEARTS-HF: Modes of Death in HFmrEF & HFpEF 26.12.2025

Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF RCT 📚 Impact 52: Finerenone and mode of death in HF: Where do we stand? A review by Dr. Soltani Moghadam, Cardiovascular Researcher.

Impact 51: Thrombolysis after recent DOAC intake 26.12.2025

📚 Impact 51: Intravenous thrombolysis in patients with ischemic stroke and recent ingestion of direct oral anticoagulants (DOACs), A review by Dr. Haeri, Neurologist.

H&H Academy in 7 minutes, Episode 7 26.12.2025

💊 Hypertension and Hyperlipidemia at your fingertips! 5️⃣ H&H Academy in 7 minutes, episode 7.

Impact 50: Thrombolysis before thrombectomy: A bridge not fallen 26.12.2025

📚 Impact 50: Thrombolysis before thrombectomy: A bridge not fallen, A review by Dr. Benam, Cardiovascular Specialist.

Case Discussion 125: DVT Prophylaxis in Post-Ischemic Stroke Patients 25.12.2025

🫀Case Discussion 125: DVT Prophylaxis in Post-Ischemic Stroke Patients, by Dr. Bikdeli, Cardiovascular specialist.

Impact 49: SGLT2 inhibitors in CKD: are they really effective in all patients? 24.12.2025

SGLT2 inhibitors in CKD: are they really effective in all patients?

Impact 48: DOACs for Rheumatic Heart Disease-Associated AF Post-Bioprosthetic MVR 23.12.2025

DOACs for Rheumatic Heart Disease-Associated AF Post-Bioprosthetic MVR

22nd ACC 2025 Congress Coverage: FLAVOUR II Trial 22.12.2025

22nd ACC 2025 Congress Coverage: FLAVOUR II Trial

Case Discussion 124: Anticoagulation in Patients with Mitral Stenosis 22.12.2025

Case Discussion 124: Anticoagulation in Patients with Mitral Stenosis

23rd ACC 2025 Congress Coverage: FAME 3 Trial 22.12.2025

23rd ACC 2025 Congress Coverage: FAME 3 Trial

21st ACC 2025 Congress Coverage: DapaTavi Trial 21.12.2025

🫀21st ACC.25 Congress Coverage: SGLT2 Inhibitors Progressing to New Standard After TAVI, DapaTAVI Trial, by Dr. Tahamtan, Fellowship of Electrophysiology. 🔸Stay tuned for more insights from the late-breaking trials presented during this magnificent scientific event.

19th ACC 2025 Congress Coverage: HPV Infection and Cardiovascular Disease 21.12.2025

19th ACC 2025 Congress Coverage: HPV Infection and Cardiovascular Disease

20th ACC 2025 Congress Coverage: ALLEPRE Trial 21.12.2025

🫀20th ACC.25 Congress Coverage: Alliance for secondary prevention after an acute coronary syndrome, ALLEPRE Trial, by Dr. Nasrollahizadeh, General Practitioner. 🔸Stay tuned for more insights from the late-breaking trials presented during this magnificent scientific event.

18th ACC 2025 Congress Coverage: SOUL Trial 21.12.2025

18th ACC 2025 Congress Coverage: SOUL Trial

L H&H Accademy in 7 Minutes, Ep 6, 50y M 19.12.2025

💊 Hypertension and Hyperlipidemia at your fingertips! 5️⃣ H&H Academy in 7 minutes, episode 6

5th ACC 2025 Congress Coverage: PURSUIT Trial 09.06.2025

5th ACC 2025: PURSUIT Trial

13th ACC 2025 Congress Coverage: EquiOx Study 09.06.2025

13th ACC 2025: EquiOx Study

11th ACC 2025 Congress Coverage: HOST-BR Trial 09.06.2025

11th ACC 2025: HOST-BR Trial

12th ACC 2025 Congress Coverage: RIVAWAR Trial 09.06.2025

12th ACC 2025: RIVAWAR Trial

Ascultă podcastul Daily cardiology în Replaio

Radio și podcasturi într-o singură aplicație - gratuit și fără înregistrare. Instaleaz-o azi și nu rata lansarea

Descarcă din Google Play

Replaio nu este editorul podcasturilor; numele emisiunilor, coperțile și materialul audio aparțin autorilor lor și sunt distribuite prin fluxuri RSS publice